Article By:
Stella Morrison
Thursday, June 11, 2020 10:44 AM EDT
New research suggests that the phytocannabinoid Cannabidiol (CBD) may have an anti-tumor effect on patients with GBM. What’s in store for future research into the disease and its management?
In this article: AMRH
AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
This is actually a pretty exciting development. Human testing is a major step. Going to take a closer look. $AMRH